Indian Court Rejects Bayer’s Plea to Halt Natco Sorafenib Exports

Bayer has suffered yet another setback in its long battle to defend its Nexavar patent in India. A recent decision permitted the local firm Natco to export a small quantity of sorafenib to Hisun of China.